Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DRG Instruments is a German in vitro diagnostics and laboratory equipment company focused on immunoassays and automated testing platforms for clinical laboratories and research users. The company develops and manufactures ELISA and chemiluminescent assays, along with automated analyzers such as DRG:HYBRiD-XL and the DxDATA CLIA platform. Its menu spans endocrinology, diabetes, prenatal and neonatal testing, thyroid testing, infectious disease and other specialty diagnostic areas, and it distributes products globally through partners in more than 110 countries. DRG also offers assay development and contract production services, making it both a product company and a diagnostics manufacturing partner. The business appears to operate as a German subsidiary within the broader DRG/BioCheck group and remains commercially active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DRG Instruments.